Rheumatology

Latest News
January 24th 2023

Using Telemedicine Interventions During COVID-19 to Expand Care Post COVID-19

January 1st 2023

Top 5 Most-Read Rheumatology Articles of 2022

December 14th 2022

Cannabis Improves Quality of Life in Women With Treatment-Resistant Fibromyalgia

December 1st 2022

Stopping Methotrexate for 1 Week After Flu Vaccine May Work as Well as 2 Weeks

November 15th 2022

Early TNF Inhibitor Initiation in Ankylosing Spondylitis Linked to Increased Cardiovascular Risk

Video Interviews
View All
April 11th 2022

ILD Risk Factors

April 11th 2022

Interstitial Lung Disease: An Overview

April 2nd 2022

Dr Christopher Phillips on Prior Authorization and Step Therapy in Rheumatology

March 18th 2022

Dr Christopher Phillips on the Insurance Challenges in Rheumatology

February 26th 2022

Dr Ted Mikuls Explains Gout Study's Regional Data, Findings on Urate Control

February 19th 2022

Dr Ted Mikuls Discusses Gout Interventions to Prevent Amputation

February 11th 2022

Dr Ted Mikuls on Gout Study: BMI Was Independent of Amputation Rate

February 3rd 2022

Dr Ted Mikuls Discusses Study on Gout, Amputation Rates in Veterans

August 26th 2021

Access to Therapy and Future Treatment Directions in Lupus Nephritis

August 24th 2021

FDA Approved Agents for Lupus Nephritis: Belimumab and Voclosporin

More News

word graphic of rheumatoid arthritis
November 11th 2022

EULAR Updates Therapy Recommendations for RA

AJMC Staff
The latest update says that Janus kinase (JAK) inhibitors should only be used if risk factors for cardiovascular disease or cancer have been considered, and that biologics are preferred.
Pharmacy shelf
October 30th 2022

Study Supports Feasibility of Integrating Specialty Pharmacists in Health Systems

Jaime Rosenberg
The program, serving patients from rheumatology, dermatology, gastroenterology, allergy, and cardiology clinics, is the first of its kind within the Veterans Health Administration, researchers said.
Artificial intelligence graphic
October 24th 2022

Adding Machine Learning to Longitudinal PRO Data May Prove Useful in RA

Jaime Rosenberg
In a proof-of-concept analysis, researchers show that machine learning methods paired with longitudinal patient-reported outcomes (PRO) data were able to classify subsequent rheumatoid arthritis (RA) disease activity after beginning treatment with a biologic
Provider checking patient with RA
October 15th 2022

Researchers Highlight Importance of Assessing Osteoporosis Risk Factors in RA

Jaime Rosenberg
Risk of osteoporosis and bone fractures in rheumatoid arthritis (RA) stem from disease-specific causes, disease treatment, and factors that face the general population, according to researchers, who highlighted the importance of assessing risk factors in these patients.
image of psoriasis
October 8th 2022

Study of IL-17A Treatment Underscores Potential of circRNA as Biomarker in Psoriasis

Jaime Rosenberg
The study, which assessed changes in circRNA and miRNA after beginning treatment with secukinumab, revealed a prompt change in circRNA abundance upon initiation of treatment and a strong correlation between circRNA and the psoriasis area and severity index.
SARS-COV-2
October 7th 2022

Patients With RA Face Higher Risk of COVID-19, Hospitalization Even When Vaccinated

Jaime Rosenberg
Based on their findings, the researchers are emphasizing the importance of patients with rheumatoid arthritis (RA) receiving a booster vaccination, as well as other mitigation strategies, such as social distancing and wearing face masks.
Painful shoulder
September 25th 2022

Tocilizumab Leads to Improvement in Patients With Active Polymyalgia Rheumatica Despite Prednisone Therapy

Jared Kaltwasser
However, patient-reported scores were not significantly better in the tocilizumab group.
Doctors discussing their researrch
September 20th 2022

Secukinumab Effective in Real-world Clinical Usage in New Study

Jared Kaltwasser
At 12 weeks, nearly 8 in 10 patients had significant improvement.
Image of clinical research
September 18th 2022

Researchers Identify Key Protein Driving Inflammation in RA

Jaime Rosenberg
The findings, produced over a 4-year period, indicate the protein sulfatase-2 (Sulf-2) may be a therapeutic target in rheumatoid arthritis (RA).
Image of methotrexate
September 16th 2022

Improved CPMs Needed for Guiding Methotrexate Use in RA

Jaime Rosenberg
The study analyzed 20 clinical prediction models (CPMs) for rheumatoid arthritis (RA), all of which were deemed to have a high risk of bias, leading the researchers to urge against their use to guide decision-making without addressing their limitations.
Sketch of lungs
September 13th 2022

Systemic Review, Survey of Physicians Provide Insight on Targeted Therapy Use in SSc-ILD

Jaime Rosenberg
Data from a literature review of 41 studies were analyzed and subsequently leveraged to create a survey among physicians on the use of 4 targeted therapies in systemic sclerosis-interstitial lung disease (SSc-ILD).
Image of a sick kid
September 7th 2022

Low-Dose Secukinumab Shows Best PASI 90 in Pediatric Plaque Psoriasis

Jaime Rosenberg
This analysis of 5 studies found that, compared with placebo, all biologic regimens improved Psoriasis Area and Severity Index (PASI) 90 response—considered a gold standard goal due to its correlation with quality of life.
messy binders with sticky notes sticking out
September 2nd 2022

RA2-DREAM Challenge Demonstrates Successful Crowdsourcing Approach in Developing Joint Damage Algorithms

Hayden E. Klein
Machine learning models collected using a crowdsourcing approach that provide feasible, quick, and accurate methods to quantify joint damage in rheumatoid arthritis (RA) could potentially be incorporated into electronic health records.
picture of person with systemic onset juvenile idiopathic arthritis
August 29th 2022

Alternative Therapies Possible for Refractory Systematic Onset JIA, Review Says

Jared Kaltwasser
About 1 in 7 people with systematic onset juvenile idiopathic arthritis (SJIA) will not respond to interleukin-1 or interleukin-6 inhibitors.
woman at dentist, close-up of teeth with dental tool
August 26th 2022

Periodontal Treatment May Improve Short-term RA Disease Activity

Hayden E. Klein
Investigators conducted a review of 21 studies on the effects of a gum disease treatment on various rheumatoid arthritis (RA) disease activity measures.
graphic of skeleton with red flare around ankle
August 23rd 2022

Secukinumab Linked to Longer Time to JIA Disease Flare

Hayden E. Klein
Juvenile idiopathic arthritis (JIA) disease flare was significantly longer in children with enthesitis-related arthritis and juvenile psoriatic arthritis treated with secukinumab compared with placebo.
wooden human figure with scribbles around head
August 19th 2022

Study Suggests Risk of Cognitive Decline, Dementia Is Not Impacted by RA Status

Hayden E. Klein
While past research suggests patients with rheumatoid arthritis (RA) are at increased risk for dementia, a Mayo Clinic study claims this is not the case.
Older Black male at pharmacy
August 17th 2022

Black Adults Face a Higher Prevalence of Gout Compared With Whites, Study Finds

Jared Kaltwasser
The new report reverses previous research suggesting that White men who consumed large amounts of gamey meat and rich foods were most at risk.
vaccine vial, syringe, and stethoscope
August 12th 2022

ACR Releases 2022 Vaccination Guideline Summary for Patients With RMDs

Hayden E. Klein
The summary includes expanded indications for certain vaccines, approaches for live-attenuated vaccines, and medication management around the time of vaccination for patients with rheumatic and musculoskeletal diseases (RMDs).
doctor writing on paper
August 10th 2022

Review Highlights Major RA Management Developments in Past Year

Hayden E. Klein
According to the review, the most important novel developments were related to the repositioning of old drugs in the context of treat-to-target (T2T) therapy and new long-term safety information on Janus kinase (JAK) inhibitors.
man holding hand to chest
August 2nd 2022

Gout Flare Linked to Increased Risk of Heart Attack, Stroke

Hayden E. Klein
Patients with gout who experienced a heart attack or stroke were twice as likely to have experienced a gout flare within the past 60 days compared with patients with gout who did not experience either event.
doctor writing on form
July 29th 2022

Study Highlights 6 Aspects of Daily Life Affected by RA

Hayden E. Klein
Interviews conducted with patients with rheumatoid arthritis (RA) revealed 6 important aspects of daily life that are rarely measured in RA research.
person holding white pills and glass of water
July 26th 2022

Early Methotrexate Did Not Prevent Arthritis Development, Study Found

Hayden E. Klein
While a 1-year course of methotrexate improved physical function, pain, morning joint stiffness, and joint inflammation, it did not prevent the development of clinical arthritis.
telemedicine appointment
July 23rd 2022

Patients Who Have Rheumatic Disease May Benefit From Telemedicine

Lindsey Mulrooney
A systemic review found that patients with rheumatic diseases experienced comparable outcomes and satisfaction from telemedicine compared with in-person treatment.
woman with fever looking at thermometer
July 21st 2022

Rheumatic Conditions Are a Common Cause of Unexplained Fever, Inflammation

Hayden E. Klein
A review found rheumatic conditions cause 22.2% of global cases of fever and inflammation of unknown origin.
patient consulting with doctor
July 12th 2022

AYAs Emphasize Importance of Patient Perspectives During Health Care Transition

Hayden E. Klein
None of the adolescent and young adult (AYA) participants in a study reported experiencing the Six Core Elements of Healthcare Transition during their rheumatology health care transition.
Image of telehealth appointment
July 10th 2022

Telerehabilitation Reduces Pain, Improves Function for People With Musculoskeletal Needs

Lindsey Mulrooney
Participants in a digital acute musculoskeletal (MSK) program experienced better pain and function outcomes vs nonparticipants, demonstrating benefits for acute and subacute MSK conditions.
FDA Approved
July 8th 2022

FDA Approves Pegloticase Injection Coadministered With Methotrexate for Gout

Hayden E. Klein
Pegloticase (Krystexxa) injection coadministered with methotrexate received FDA approval for the treatment of gout.
white pills falling out of pill bottle
July 1st 2022

Safety Trends Following DMARD Treatment in Patients With RA

Hayden E. Klein
Researchers found that risk of adverse events and mortality did not increase following certain rheumatoid arthritis (RA) treatments.
Overweight female out for walk with friend
June 30th 2022

Treatment Outcomes for Patients With AS, PsA May Be Impacted by Time to Diagnosis, Gender, BMI

Lindsey Mulrooney
Outcomes for patients with ankylosing spondylitis (AS) and psoriatic arthritis (PsA) may depend on gender, time to diagnosis, and body mass index (BMI), according to subanalyses of the AQUILA study of patients taking secukinumab.
12345678
...
11>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo